Study objective: To determine the diagnostic yield, morbidity, mortality, a
nd therapeutic impact of the open lung biopsy in patients requiring mechani
cal ventilation,
Design: Retrospective review of patient records.
Setting: Tertiary ICU. Patients:
Patients with respiratory failure and diffuse pulmonary infiltrates requiri
ng mechanical ventilation, leading up to or following an open lung biopsy.
Measurements: Information included patient demographics, organ failure, mic
robiological results before open-lung biopsy, PaO2/fraction of inspired oxy
gen values before and after biopsy, immunosuppression, timing of open lung
biopsy, biopsy-related morbidity and mortality, duration of after-biopsy ve
ntilation, open lung biopsy results, biopsy-initiated treatment alterations
, and hospital outcome,
Results: Twenty-four patients were identified, The mean age was 48.9 years
(confidence interval, 42.1 to 55.7). Twenty-one percent had respiratory inf
ections diagnosed before open lung biopsy but not confirmed by open lung bi
opsy. Intraoperative complications occurred in 21% of patients, and postope
rative complications occurred in 17% of patients. Operative mortality was 8
.4%. The specific and the nonspecific diagnostic rates were both 46%. Lung
histology was normal in two patients; one of those patients had a false-neg
ative finding. No patient with respiratory failure plus greater than or equ
al to 2 other organ failures survived. Alteration of therapy did not differ
entiate between survivors. Open lung biopsy-guided alteration of therapy di
rectly benefited 39%, and withdrawal was possible in 8.4% of the patients.
Conclusions: The multiple organ dysfunction score should be considered when
deciding the relative risk of performing an open lung biopsy, which in thi
s group of patients provided a specific diagnosis in 46% and carried a mort
ality rate of 8.4%.